Home › Asset managers › Compare 2025-2026 › Goldman Sachs vs John Hancock
Goldman Sachs 2025-2026 · John Hancock 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 18,938 | 16,677 | 928 | 1,333 | 94.7% | 92.2% |
| Board proposals | 15,717 | 13,856 | 865 | 996 | 94.1% | 91.8% |
| E&S shareholder proposals | 154 | 83 | 9 | 62 | 90.2% | 83.5% |
| Other items | 3,067 | 2,738 | 54 | 275 | 98.1% | 94.3% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
928 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Goldman Sachs | John Hancock |
|---|---|---|---|---|---|---|
| WEBSTER FINANCIAL CORPORATION | May 26, 2026 | To approve, on an advisory (non-binding) basis, the compensation payments that will or may be paid to Webster's named executive officers in connection with the transactions contemplated by the Transaction Agreement (the "compensation proposal"). Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| WESBANCO, INC. | April 15, 2026 | To approve an advisory (non-binding) vote on compensation paid to Wesbanco's named executive officers in 2025. Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 7 funds |
| WESTAMERICA BANCORPORATION | April 23, 2026 | Approve a non-binding advisory vote on the compensation of our executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 6 funds |
| WEYCO GROUP, INC. | May 5, 2026 | Advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 5 funds |
| WHEELS UP EXPERIENCE INC. | June 9, 2026 | Approval of an amendment to the Wheels Up Experience Inc. 2021 Long-Term Incentive Plan, as amended and restated April 1, 2023 (as previously amended by Amendment No. 1 thereto and Amendment No. 2 thereto, the "A&R 2021 LTIP"), to increase the aggregate number of shares of the Company's Class A common stock, $0.0001 par value per share available for awards made under the A&R 2021 LTIP and extend the termination date of such plan to March 31, 2036. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| WHEELS UP EXPERIENCE INC. | June 9, 2026 | The non-binding, advisory vote to approve named executive officer compensation for the fiscal year ended December 31, 2025. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| WILLIS LEASE FINANCE CORPORATION | June 23, 2026 | Cast an advisory vote to approve the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 6 funds |
| WILLIS LEASE FINANCE CORPORATION | June 23, 2026 | Elect one Class I Director to serve until the 2029 Annual Meeting of Stockholders, specifically and as nominated by the Board of Directors. Stephen Jones Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 4 funds |
| WORKDAY INC | June 16, 2026 | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 12 funds |
AGAINST 12 funds |
| WORKDAY, INC. | June 16, 2026 | To approve the amendment and restatement of our 2012 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance. Compensation |
Board | For | FOR 10 funds |
AGAINST 9 funds |
| WORKDAY, INC. | June 16, 2026 | To approve the amendment and restatement of our 2022 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance. Compensation |
Board | For | FOR 10 funds |
AGAINST 9 funds |
| WORKIVA INC. | May 28, 2026 | Approval of the Amendment and Restatement of the Workiva Inc. 2014 Equity Incentive Plan to increase the number of shares that may be issued under the Plan. Compensation |
Board | For | FOR 3 funds |
AGAINST 4 funds |
| WORKIVA INC. | May 28, 2026 | Election of Directors: Michael M. Crow, Ph.D. Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 4 funds |
| WORLD ACCEPTANCE CORPORATION | August 20, 2025 | APPROVE THE WORLD ACCEPTANCE CORPORATION 2025 STOCK INCENTIVE PLAN. Compensation |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| Warner Bros. Discovery, Inc. | April 23, 2026 | To approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to WBD's named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 3 funds |
| XERIS BIOPHARMA HOLDINGS, INC. | June 4, 2026 | To elect two Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Dawn Halkuff Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 3 funds |
| XEROX HOLDINGS CORPORATION | May 20, 2026 | Approve an amendment to the Xerox Holdings Corporation 2024 Equity and Performance Incentive Plan to increase the share reserve. Compensation |
Board | For | FOR 1 fund |
AGAINST 4 funds |
| YPSOMED HOLDING AG | July 2, 2025 | REELECT SIMON MICHEL AS DIRECTOR Director Elections |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| ZAI LAB LTD | June 17, 2026 | THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| ZEALAND PHARMA A/S | March 26, 2026 | APPROVE REMUNERATION OF DIRECTORS IN THE AMOUNT OF DKK 100,000 FOR EACH DIRECTOR, AND 5,000 RSU FOR CHAIR, 1,000 RSU FOR VICE CHAIR AND 1,500 RSU FOR OTHER DIRECTORS; APPROVE REMUNERATION FOR COMMITTEE WORK IN RSUS Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| ZEALAND PHARMA A/S | March 26, 2026 | REELECT ALF GUNNAR MARTIN NICKLASSON AS DIRECTOR Director Elections |
Board | For | FOR 5 funds |
ABSTAIN 1 fund |
| ZEALAND PHARMA A/S | March 26, 2026 | REELECT ENRIQUE CONTERNO AS DIRECTOR Director Elections |
Board | For | FOR 5 funds |
ABSTAIN 1 fund |
| ZEALAND PHARMA A/S | March 26, 2026 | REELECT LEONARD KRUIMER AS DIRECTOR Director Elections |
Board | For | FOR 5 funds |
ABSTAIN 1 fund |
| ZENAS BIOPHARMA, INC. | May 11, 2026 | To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: James Boylan Director Elections |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| ZENTALIS PHARMACEUTICALS, INC. | June 16, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| ZETA GLOBAL HOLDINGS CORP. | June 16, 2026 | Election of Directors: Jeanine Silberblatt Director Elections |
Board | For | FOR 8 funds |
WITHHOLD 4 funds |
| ZEVRA THERAPEUTICS, INC. | June 4, 2026 | Election of Directors: Douglas W. Calder Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 3 funds |
| ZILLOW GROUP, INC. | June 2, 2026 | Election of Directors: Jay C. Hoag Director Elections |
Board | For | FOR 3 funds |
AGAINST 3 funds |
← Previous Page 10 of 10
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.